Gleevec (imatinib) is a prescription oral tablet used to treat certain types of cancer or blood disorders. It can interact with some supplements and other medications, such as certain seizure drugs ...
WASHINGTON, Dec 3 (Reuters) - A redesigned version of Novartis AG's cancer drug Gleevec may avoid a rare heart-related side effect while more specifically targeting a type of stomach cancer, ...
Nonadherence to Gleevec in GIST patients is common, with cognitive functioning, TDM, and social support as key indicators. A machine learning model using 64 covariates identified 19 significant ...
Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia had better MRD statuses after receiving Iclusig, compared with Gleevec. Patients with newly diagnosed Philadelphia ...
NEW YORK, June 5 (Reuters) - Bristol-Myers Squibb's cancer drug Sprycel was superior to the highly effective Gleevec in treating newly diagnosed patients with chronic myeloid leukemia, researchers ...
Patients with advanced non-progressing gastrointestinal stromal tumors (GIST) who discontinued imatinib had more rapid progression, faster development of resistance, and worse overall survival (OS), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results